Apex Biotechnology Corp Capital Reinvestment Ratio
Apex Biotechnology Corp capital reinvestment ratio. Apex Biotechnology Corp (1733) has a Capital Reinvestment Ratio of 0.57x as of September 2025, meaning it reinvests 1% of its operating cash flow (NT$5.19 Million) in capital expenditures (NT$2.97 Million). See Apex Biotechnology Corp free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Apex Biotechnology Corp (2002–2024)
Capital reinvestment ratio of Apex Biotechnology Corp from 2002 to 2024. This chart tracks Apex Biotechnology Corp's Capital Reinvestment Ratio across 23 annual periods. See financial agility of Apex Biotechnology Corp to measure the company's free cash flow as a share of total liabilities.
Apex Biotechnology Corp Capital Reinvestment Ratio by Year (2002–2024)
Apex Biotechnology Corp capital reinvestment ratio by year from 2002 to 2024. For the full cash flow conversion analysis, see cash flow conversion of Apex Biotechnology Corp.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | NT$328.67 Million | NT$29.63 Million | ▼ -16.8% |
| 2023 | 0.11x | NT$230.39 Million | NT$24.98 Million | ▼ -92.8% |
| 2022 | 1.51x | NT$26.62 Million | NT$40.20 Million | ▲ +936.9% |
| 2021 | 0.15x | NT$179.87 Million | NT$26.20 Million | ▼ -15.4% |
| 2020 | 0.17x | NT$280.60 Million | NT$48.32 Million | ▲ +40.8% |
| 2019 | 0.12x | NT$462.52 Million | NT$56.58 Million | ▼ -89.0% |
| 2018 | 1.11x | NT$67.57 Million | NT$75.29 Million | ▲ +194.9% |
| 2017 | 0.38x | NT$70.83 Million | NT$26.76 Million | ▲ +192.8% |
| 2016 | 0.13x | NT$298.06 Million | NT$38.45 Million | ▲ +128.5% |
| 2015 | 0.06x | NT$472.15 Million | NT$26.66 Million | ▼ -76.9% |
| 2014 | 0.24x | NT$267.60 Million | NT$65.41 Million | ▼ -52.2% |
| 2013 | 0.51x | NT$484.77 Million | NT$247.69 Million | ▼ -37.2% |
| 2012 | 0.81x | NT$509.67 Million | NT$414.70 Million | ▲ +198.1% |
| 2011 | 0.27x | NT$273.45 Million | NT$74.63 Million | ▼ -21.1% |
| 2010 | 0.35x | NT$465.59 Million | NT$161.05 Million | ▲ +84.6% |
| 2009 | 0.19x | NT$391.29 Million | NT$73.34 Million | ▼ -56.7% |
| 2008 | 0.43x | NT$299.96 Million | NT$129.74 Million | ▲ +188.3% |
| 2007 | 0.15x | NT$364.62 Million | NT$54.71 Million | ▲ +30.0% |
| 2006 | 0.12x | NT$363.71 Million | NT$41.99 Million | ▼ -69.9% |
| 2005 | 0.38x | NT$212.14 Million | NT$81.30 Million | ▼ -66.7% |
| 2004 | 1.15x | NT$218.54 Million | NT$251.16 Million | ▲ +518.0% |
| 2003 | 0.19x | NT$302.25 Million | NT$56.21 Million | ▼ -75.8% |
| 2002 | 0.77x | NT$79.49 Million | NT$61.13 Million | — |